These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 847107)

  • 21. Sites of x-irradiation-induced damage in the microsomal drug metabolizing enzyme system of rat liver during development.
    Yukawa O; Nakazawa T
    Radiat Res; 1973 Oct; 56(1):140-9. PubMed ID: 4355248
    [No Abstract]   [Full Text] [Related]  

  • 22. [The state of the microsomal oxidative system in the liver of rats with acute osteomyelitis of the mandible].
    Nadzhimutdinov KN; Azimov MI; Krakovskiĭ ME; Ashirmetov AKh
    Vopr Med Khim; 1987; 33(3):101-4. PubMed ID: 3630001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age- and sex-related effects on hepatic drug metabolism in rats chronically exposed to dietary atrazine.
    Ugazio G; Bosio A; Nebbia C; Soffietti MG
    Res Commun Chem Pathol Pharmacol; 1991 Aug; 73(2):231-43. PubMed ID: 1784837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver monooxygenase activity after multiple application of nifedipin, verapamil and diltiazem.
    Koleva M; Stoytchev T
    Acta Physiol Pharmacol Bulg; 1990; 16(4):16-22. PubMed ID: 2130625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hexobarbital sleeping time in male rats with hepatic injury.
    Varga F; Fischer E
    Acta Physiol Acad Sci Hung; 1969; 36(4):431-9. PubMed ID: 5376036
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of caffeine on barbiturate sleeping time and brain level.
    Aeschbacher HU; Atkinson J; Domahidy B
    J Pharmacol Exp Ther; 1975 Mar; 192(3):635-41. PubMed ID: 1120961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Metabolic drug-drug interactions of chlorphenethiazine and chlorpromazine].
    Borchert HH; Pfeifer S; Bina B
    Pharmazie; 1984 Jan; 39(1):46-8. PubMed ID: 6718468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effect of sandimmun on the activity of mixed-function mono-oxidases in the liver microsomes].
    Astashkin EI; Prikhod'ko AZ
    Eksp Klin Farmakol; 1994; 57(6):40-2. PubMed ID: 7756960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A comparative evaluation of the changes in the duration of "hexenal sleep" in acute radiation and combined radiation-thermal lesions].
    Moiseeva LA; Budagov RS; Khlopovskaia EI
    Radiobiologiia; 1992; 32(2):299-303. PubMed ID: 1598406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of some antibiotics on hexobarbitone sleeping time in rats.
    Phansalkar AG; Balwani JH
    Hindustan Antibiot Bull; 1970 May; 12(4):179-80. PubMed ID: 5469705
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of beta-thiamino ketones on the amidopyrine-N-demethylation in vitro and in vivo as well as on hexobarbital sleeping time and L-ascorbic acid excretion in rats].
    Klinger W; Peter EM; Schirrmeister M
    Arch Int Pharmacodyn Ther; 1973 May; 203(1):16-22. PubMed ID: 4725332
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies on the effects of methylmercury on ethylmorphine N-demethylase and aniline hydroxylase activities and on the conversion of cytochrome P-450 to cytochrome P-420.
    Alvares AP; Cohn J; Kappas A
    Drug Metab Dispos; 1974; 2(3):259-66. PubMed ID: 4153087
    [No Abstract]   [Full Text] [Related]  

  • 33. Metabolic fate of the new anti-ulcer drug enprostil in animals. 4th communication: effect on hepatic drug metabolizing enzyme system in rats.
    Yamada Y; Nakahara M; Kohno M; Otsuka M; Takaiti O
    Arzneimittelforschung; 1989 Mar; 39(3):356-60. PubMed ID: 2502989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stereoselective metabolism of the enantiomers of hexobarbital.
    Furner RL; McCarthy JS; Stitzel RE; Anders MW
    J Pharmacol Exp Ther; 1969 Oct; 169(2):153-8. PubMed ID: 5824599
    [No Abstract]   [Full Text] [Related]  

  • 35. Interaction between manganese and phenobarbital on hexobarbital hypnosis in the male rat.
    Deimling MJ; Schnell RC
    Res Commun Chem Pathol Pharmacol; 1983 Jul; 41(1):165-8. PubMed ID: 6622829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of metyrapone on liver microsomal drug oxidations.
    Leibman KC
    Mol Pharmacol; 1969 Jan; 5(1):1-9. PubMed ID: 4392111
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhibition of drug metabolism. 3. Inhibition of hexobarbital metabolism in the intact rat and in the isolated perfused liver by 2-diethylaminoethyl 2,2-diphenylvalerate HC1 (SKF 525-A) and its N-deethylated derivatives.
    Stitzel RE; Anders MW; Mannering GJ
    Mol Pharmacol; 1966 Jul; 2(4):335-40. PubMed ID: 5968073
    [No Abstract]   [Full Text] [Related]  

  • 38. Tolerance development to cadmium-induced alteration of drug action.
    Roberts SA; Miya TS; Schnell RC
    Res Commun Chem Pathol Pharmacol; 1976 May; 14(1):197-200. PubMed ID: 935651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of iron, riboflavin and iodide deficiencies on hepatic drug-metabolizing enzyme systems.
    Catz CS; Juchau MR; Yaffe SJ
    J Pharmacol Exp Ther; 1970 Aug; 174(2):197-205. PubMed ID: 5451357
    [No Abstract]   [Full Text] [Related]  

  • 40. Disulfiram impairment of drug metabolism by rat liver microsomes.
    Stripp B; Greene FE; Gillette JR
    J Pharmacol Exp Ther; 1969 Dec; 170(2):347-54. PubMed ID: 4391007
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.